Poor quality of adverse event reporting in oncology phase III trials: A systematic review

被引：0
|
作者：
Maillet, D. [1 ]
You, B. [1 ]
Peron, J. [1 ]
机构：
[1] Hop Lyon Sud, Pierre Benite, France
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
906
引用
收藏
页码：S193 / S194
页数：2
相关论文
共 50 条
  • [1] Quality of adverse event reporting in phase III randomized controlled trials of breast and colorectal cancer: A systematic review
    Komorowski, Adam S.
    MacKay, Helen J.
    Pezo, Rossanna C.
    CANCER MEDICINE, 2020, 9 (14): : 5035 - 5050
  • [2] Adverse events reporting in phase III oncology clinical trials of checkpoint inhibitors: A systematic review
    Joulia, M-L.
    Barhli, A.
    Tournigand, C.
    Kempf, E.
    ANNALS OF ONCOLOGY, 2020, 31 : S725 - S725
  • [3] Variations in adverse event reporting in phase III head and neck trials (1990 to 2003): A systematic review
    Gwede, CK
    Saranga, S
    Lee, J
    Beam, C
    Djulbegovic, B
    Trotti, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S352 - S352
  • [4] Adherence to CONSORT adverse event reporting guidelines in medical oncology clinical trials, a systematic review
    Peron, J.
    Maillet, D.
    Gan, H. K.
    Chen, E. X.
    You, B.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S192 - S192
  • [5] Evaluation of the quality of the reporting of phase II clinical trials in oncology: A systematic review
    Rivoirard, Romain
    Langrand-Escure, Julien
    Oriol, Mathieu
    Tinquaut, Fabien
    Chauvin, Franck
    Rancoule, Chloe
    Magne, Nicolas
    Bourmaud, Aurelie
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 125 : 78 - 83
  • [6] The quality of reporting of phase II and III trials for new antipsychotics: a systematic review
    Patel, M. X.
    Collins, S.
    Hellier, J.
    Bhatia, G.
    Murray, R. M.
    PSYCHOLOGICAL MEDICINE, 2015, 45 (03) : 467 - 479
  • [7] Adverse events reporting in phase 3 oncology clinical trials of checkpoint inhibitors: A systematic review
    Barhli, Aline
    Joulia, Marie-Liesse
    Tournigand, Christophe
    Kempf, Emmanuelle
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 157
  • [8] Adverse event reporting in oncology clinical trials - lost in translation?
    Sivendran, Shanthi
    Galsky, Matthew D.
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (07) : 893 - 896
  • [9] Adverse Event Reporting Quality in Cancer Clinical Trials Evaluating Immune Checkpoint Inhibitor Therapy: A Systematic Review
    Wang, Yuhong
    Chen, Chen
    Du, Wei
    Zhou, Yixin
    He, Lina
    Hong, Shaodong
    Zhang, Li
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [10] Quality of reporting in oncology phase II trials: A 5-year assessment through systematic review
    Langrand-Escure, Julien
    Rivoirard, Romain
    Oriol, Mathieu
    Tinquaut, Fabien
    Rancoule, Chloe
    Chauvin, Frank
    Magne, Nicolas
    Bourmaud, Aurelie
    PLOS ONE, 2017, 12 (12):
12345